Source: International Congress 2018 – Airway disease: recent discoveries
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Haagensen Andersen (Aarhus, Denmark), L. Mølgaard Pedersen (Aarhus, Denmark), A. Bjerrum (Aarhus, Denmark). Inhaler technique assessments in a real-life cohort of mepolizumab-treated patients. 4431

Member's Comments

No comment yet.

Related content which might interest you: Use of inhaler devices in elderly patients with respiratory disease: real-world observational study Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Preference of the inhaler device and assessment of the technique among the asthmatic and COPD patients Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 Physician assessment of asthma control in patients receiving omalizumab in a real-world setting Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Devise use errors among patients with asthma and COPD-A real-life study Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Health status changes in COPD patients after real-life switch from tiotropium or salmeterol/fluticasone to indacaterol/glycopyrronium using the EQ-5D-3L instrument: results from the POWER study Source: International Congress 2018 – COPD management Year: 2018 Budesonide/formoterol improves the wellbeing of patients with COPD: results from a real-life setting Source: Eur Respir J 2005; 26: Suppl. 49, 289s Year: 2005 Switch from Symbicort Turbuhaler to Bufomix Easyhaler; a real-life prospective study in asthma patients Source: International Congress 2018 – Clinical markers of asthma Year: 2018 Characteristics of patients receiving mepolizumab in real-world practice –REALITI-A study Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Evaluation of the teach-to-goal method in improving inhaler technique in paediatric asthma patients Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021 Late Breaking Abstract - A randomized clinical study to assess the impact of budesonide/formoterol (BUD/FM) pMDI medication reminders on adherence in COPD patients Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 Assessment of handling of inhaler devices in real life in 3811 patients Source: Eur Respir J 2003; 22: Suppl. 45, 474s Year: 2003 Biomarker measurement in asthma patients receiving biologic therapy: a real-world retrospective study Source: International Congress 2018 – Eosinophils in airway disease Year: 2018 Simulated-use study of inhaler usability in patients with COPD Source: International Congress 2017 – COPD management Year: 2017 A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma Source: Eur Respir J, 51 (1) 1701126; 10.1183/13993003.01126-2017 Year: 2018 Real-life inhaler technique in asthma patients using the electronic ProAir Digihaler Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 Switch from LABA+ICS to a LABA/LAMA combination in symptomatic women with COPD – an analysis of the observational DACCORD study Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Assessment of inhalation technique and satisfaction with inhalers in asthmatic patients Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium Source: ERJ Open Res, 5 (4) 00253-2018; 10.1183/23120541.00253-2018 Year: 2019 Handling of inhalers by COPD patients in actual clinical practice Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care Year: 2020 Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021